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Abstract-NC-1 300 (10-100 mg/kg), given p.o. at 0.5, 6, 12 or 24 hr before HCI ethanol, dose-dependently protected the rat gastric mucosa. This protection was observed even when the gastric contents had been removed before application of HCI ethanol.
NC-1300 (30 mg/kg), given i.p., was without effect on lesion formation in a dose which potently inhibited gastric acid secretion in pylorus ligated rats. Pretreatment with indomethacin (5 mg/kg, s.c.) resulted in no reduction in the protection by NC-1300, excluding the possible participation of endogenous prostaglandins in the protective mechanism. N-ethyl maleimide pretreatment (10 mg/kg, s.c.) slightly reduced the protective activity of NC-1300, suggesting the partial participation of endogenous sulfhydryl compounds in the NC-1300 protection.
NC-1300 sulfide and mercaptobenzimidazole (compounds obtained after mixing NC-1300 with acidic solution) also dose-dependently protected against HCl-ethanol-induced lesions when given p.o. at 0.5 hr before HCI ethanol. The protection was significant but was considerably reduced in contrast to NC 1300 when the compounds were given 12 hr beforehand. NC-1300 sulfone had no effect on lesion formation.
Omeprazole (10, 30 mg/kg), given p.o., also dose dependently inhibited HCl-ethanol -induced lesions. However, the duration of protection was shorter than that seen with NC-1300, i.e., the effect disappeared 12 hr later. Thus, NC-1300 has a potent and long-lasting activity on HCI•ethanol induced gastric lesions.
The mechanism by which this occurs remains unknown.
We recently reported that NC-1300, a new proton pump inhibitor, is a potent inhibitor of gastric acid secretion in rats and that this action persisted for more than 24 hr after a single p.o. administration (1) . In addition, the compound markedly protected the gastric mucosa against injury induced by pylorus-ligation, water-immersion stress, aspirin and indomethacin, and the duodenal mucosa against mepirizole. The mechanism by which NC-1300 inhibits these lesions appears to relate to its antisecretory property.
There are reports that proton pump in hibitors such as omeprazole or timoprazole protect the gastric mucosa against necro tizing agents, including ethanol, HCI, or boiling water (2) (3) (4) . These findings indicate that such compounds have cytoprotective activity which is unrelated to their anti secretory effects. The present study was designed to determine if NC-1300 has also a cytoprotective activity on HCI•ethanol induced gastric lesions in rats. NC-1 300 was mixed in acidic solution and three major compounds were obtained (NC-1300 sulfide, mercaptobenzimidazole, NC-1300 sulfone) (Fig. 1) . The effects of these materials on HCl-ethanol -induced lesions were also studied in comparison with those obtained with NC-1300.
Omeprazo!e, an established proton pump inhibitor (5), was used as a reference drug.
Materials and Methods
Male Sprague-Dawley rats (230-270 g, Charles-River Japan) were deprived of food for 24 hr before the experiments. Water was given freely for the initial 22 hr, but was who determined the lesions had no knowledge of which treatment the animals had been given.
Gastric secretion: Antisecretory activities of NC-1300 and omeprazole were studied using pylorus ligation preparations. Under ether anesthesia, the abdomen was incised, the pylorus ligated, and the animals killed 3 hr later. The gastric contents were collected and analyzed for volume and acidity. Acidity was determined by automatic titration of the gastric juice against 0.1 N NaOH to pH 7.0 (Autoburette). Titratable acid output was expressed as /LEq/hr. NC-1300, omeprazole, or the vehicle alone was given p.o. or i.p. at 10 or 30 mg/kg at 0.5 hr before ligating the pylorus.
Drugs: NC-1300, Sulfide, Sulfone and omeprazole were all gifts from Nippon Chemiphar and MBI was purchased from Janssen.
Analysis of data: Student's t-test was used to determine the statistical significance of the data, and a P<0.05 value was regarded as significant. All data represent the mean±one S.E.M.
Results
Effects of NC-1300 and omeprazole on HCI-ethanol -induced gastric lesions: In all the control rats given the vehicle alone and HCI-ethanol p.o., severe mucosal lesions developed in the glandular stomach 1.5 hr later. These lesions consisted of elongated bands of necrosis. The mean lesion length was 99.8±9.0 mm. Pretreatment with NC 1300 (3-30 mg/kg), p.o., at 0.5 hr before the HCI-ethanol administration dose dependently inhibited HCI•ethanol-induced lesions (Fig. 2) . With a dose of 30 mg/kg, lesion formation was almost completely inhibited. Omeprazole (30 mg/kg) also sig nificantly inhibited the lesion formation by 74.3%. Neither NC-1300 nor omeprazole (30 mg/kg) protected the surface epithelium of rat gastric mucosa against necrosis induced by HCI-ethanol as determined histologically. However, the deeper layer of the gastric mucosa was protected from HCI•ethanol induced damage. Pretreatment with NC Protection of the gastric mucosa by NC-1300 was nearly complete, indicating the long-lasting activity of the compound. 1300 (30 mg/kg), p.o., at 6 or 12 hr before HCI•ethanol administration also significantly inhibited lesion formation (Figs. 3 and 4), the inhibition being practically complete or at least 85.6%, respectively. Even 24 hr after the administration of 30 mg/kg, there was a 37.3% inhibition of HCI-ethanol-induced lesions. It seems remarkable that an almost total protection of the gastric mucosa against HCI-ethanol -induced lesions was apparent even 24 hr after the p.o. administration of NC 1300 (100 mg/kg). Omeprazole (30 mg/kg), given 6 hr before HCI•ethanol administration, also inhibited the lesion formation by 52.6%. However, the protection by omeprazole disappeared when given 12 hr beforehand.
Influence of dilution by gastric contents: Removal of the gastric contents 0.5 hr after NC-1300 (10 or 30 mg/kg) or omeprazole (10 or 30 mg/kg) administration did not influence the protective activity of these compounds on HCI-ethanol -induced lesions (Fig. 5) . Rather, a significant protection was observed in the dose of 10 mg/kg of each compound, i.e., the inhibition was 73.0%
with the NC-1300 treatment and 52.9% with the omeprazole treatment. Effects of i.p. administration: The i.p. administration of NC-1300 (10 or 30 mg/kg) and omeprazole (10 or 30 mg/kg) at 0.5 hr before HCI•ethanol administration had little or no effect on the lesion formation (Fig. 6) .
Effects of NC-1300 and omeprazole on gastric secretion: The p.o. administration of NC-1300 (10 and 30 mg/kg) had no effect on the volume of gastric contents, but did significantly inhibit gastric acid output for 3 hr (Fig. 7) . However, the i.p. administration of NC-1300 (10 and 30 mg/kg) significantly inhibited both the volume and acid output. maleimide (10 mg/kg) had no effects on HCl-ethanol -induced lesions (Fig. 9) . In N ethylmaleimide treated rats, NC-1300 or omeprazole at a dose of 10 mg/kg gave no protection against the lesion formation induced by HCI•ethanol, but a dose of 3C mg/kg was significantly protective. Effects of Sulfide, MBI and Sulfone on HCl-ethanol -induced lesions: Sulfide (10 or 30 mg/kg) significantly and dose-depen dently protected against the lesion formation when given p.o. at 0.5 hr before HCI-ethanol administration (Fig. 10) . The degree of protection was comparable to that observed with NC-1300, i.e., the inhibition was 40.2% at 10 mg/kg and 80.7% at 30 mg/kg. Sulfone (30 mg/kg) had no effect on the lesion formation. Both Sulfide and MBI (30 mg/kg) also significantly protected the gastric mucosa when given 12 hr before HCI ethanol administration (Fig. 11) . However, the effects of these compounds were sig nificantly weaker than those of NC-1300, the inhibition being 37.3% at 30 mg/kg of Sulfide and 27.1 % at 30 mg/kg of MBI.
Discussion
We obtained evidence that NC-1300, like other proton pump inhibitors, protects the gastric mucosa from necrotizing agents such as HCI•ethanol.
The apparent difference between NC-1300 and other compounds was the duration of this protective effect. and mild irritants, is reportedly about 1-8 hr after a single adminis tration (8) (9) (10) (11) . Thus, the protective activity of NC-1300 seen even 24 hr after a single p.o. administration was remarkable. In this regard, NC-1300 seems to be the longest lasting cytoprotective agent so far developed.
The mechanisms related to the ex traordinarily long effect include the following. First, this persistent activity of NC-1300 is comparable to the antisecretory activity of the agent. In an earlier study, we found that NC-1300 at the same dose levels used in this study inhibited the gastric acid secretion in pylorus-ligated rats for 24 hr (1). Other investigators (2-4) suggested that the protection by omeprazole or timoprazole appears to be unrelated to its antisecretory activity, because the protection was ineffec tive when these agents were given paren terally. The antisecretory activity of such agents was practically equal whether given p.o. or parenterally (i.p., s.c., or i.v.). We also found that the i.p. administration of NC-1300 or omeprazole (10 or 30 mg/kg) had no effect on HCI ethanol-induced lesions. With that dose and route, the gastric acid secretion was potently inhibited for 3 hr. These data suggest that the protective effect of NC-1300 or omeprazole is not due to its antisecretory activity, but rather to a local action. In addition, we induced gastric mucosal lesions by giving an excess amount of HCI together with ethanol directly into the stomach. This experimental condition also rules out the possible involvement of antisecretory effects of these agents in the mucosal protect on.
Second, several investigators considered that the possible dilution of necrotizing agents by gastric contents may relate to the cytoprotective effects of various compounds (12) (13) (14) , because these compounds were usually given p.o. in a volume of 1 ml or more at 0.5 to 1 hr before the agents. Most of these workers demonstrated that cytopro tection was not caused by a simple physical dilution of necrotizing agents, but rather by a pharmacological effect. We also obtained evidence that the NC-1300 protection is not due to physical dilution of HCI ethanol, because preliminary removal of gastric con tents did not alter the protection; rather, the protection was enhanced at a dose of 10 mg/ kg of NC-1300.
The mechanism of this increased effect of NC-1300 is not yet clear.
Third, it has been reported that mild irritants such as 25% ethanol or 0.35 N HCI are cytoprotective against strong irritants, possibly through the stimulation of pro staglandin synthesis by the stomach (10, 15) . We examined whether NC-1300 acts as a mild irritant mediated by endogenous pro staglandins and found that indomethacin did not block the protection afforded by NC-1300. Therefore, it is likely that endogenous prostaglandins are not involved in the mecha nism of the protective action of the agent.
Szabo et al. (16), Ezer (17) and Miller et al. (18) proposed that sulfhydryl compounds in the gastric mucosa play an important role on the cytoprotection seen with several agents. However, there are controversial data about the role of sulfhydryl compounds (mainly reduced glutathione) in the role of gastric cytoprotection.
Konturek et al. (19) reported that both sulfhydryl containing compounds such as cysteamine or sulfhydryl blockers such as diethyl maleate have a cytoprotective effect against absolute ethanol. We showed that while N-ethylmaleimide had no effect on the formation of HClethanol-induced lesions, the agent counteracted the cyto protection by NC-1300 to some extent, thereby suggesting that NC-1300 protection may partly involve sulfhydryl compounds in the stomach.
Omeprazole is readily degraded by acidic pH or metabolized in the body resulting in omeprazole-sulfone or omeprazole-sulfide (20) . Since NC-1300 was given p.o. without mixing with NaHCO3, there is the possibility that the NC-1300 protection may be due to degradation in the stomach. Actually, two agents (Sulfide and MBI) showed a similar protective effect on HCI ethanol-induced lesions, although the doses related to the protection were the same as NC-1300. It seems likely that NC-1300 exerts its pro tective effect partly by being transformed to Sulfide or MBI. However, when NC-1300, Sulfide or MBI was given 12 hr before HCI ethanol, only NC-1300 showed a marked inhibitory effect on lesion formation. Pro tection by Sulfide and MBI was weaker than that seen with NC-1300 itself. These data suggest that the protection by NC-1300 is mainly caused by the agent itself and partly due to its degradation.
Whether or not NC 1300 dissolved in an acidic solution is also effective against HCI-ethanol -induced lesions is the subject of an ongoing study.
Since gastric motility in rats was inhibited by NC-1300 (30 mg/kg) for over 0.5 hr (S. Okabe et al., unpublished data), it is unlikely that the protection by the agent is due to the enhanced emptying of HCI ethanol into the duodenum.
Takeuchi and Nobuhara (21) recently reported that gastric hypercontraction elicited by various necro tizing agents, including absolute ethanol, in rats plays an important role in the pathoge nesis of lesion formation. In contrast to their findings, HCI•ethanol did not induce any appreciable hypercontraction of the stomach, except for the increase in internal pressure (S. Okabe et al., unpublished data). Therefore, NC-1300 protection may be caused through mechanisms other than the inhibition of the gastric hypercontraction.
Another possibility is that since the viscosity of gastric contents appeared to be increased after NC-1300 treatment, an increase in mucus secretion may be involved in the causal factor. However, the degree of viscosity of gastric contents seems to be fairly equal with p.o. or i.p. drug adminis trations. This finding may exclude the possible participation of mucus in the cytopro tective effect of NC-1300.
The viscosity, mucus secretion and gastric mucosal circu lation will be determined quantitatively and reported in detail elsewhere. All those findings taken together suggest that various proton pump inhibitors, including NC-1300, protect the gastric mucosa against necrotic lesions through mechanisms unrelated to proton pump inhibition.
We conclude that regardless of the mechanism of action, NC-1300 has a potent and long-lasting protective effect on HCIh ethanol-induced gastric lesions in rats.
